Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
calendar, Carlo, checkpoint, Drapkin, Dylla, inhibitor, Kimberlee, Monte, MSD, neuromuscular, panel, pembrolizumab, qualitative, referenced, regain, Scott, simulation, unilaterally
Removed:
adjustment, ASU, authority, back, biopharmaceutical, borrowing, building, cease, challenging, Codification, commercializing, competing, consideration, consultant, covered, credit, curtail, dementia, designated, difficult, discontinue, eliminate, EMA, emergence, enable, encounter, enhancing, enrollment, European, expand, expanding, FDA, forced, frontotemporal, guidance, headcount, history, impacted, infusion, initiated, involving, length, lobar, pandemic, planned, profitability, pursuit, quality, receipt, recognition, recommendation, reduction, registration, Richard, secure, seeking, selling, sooner, successful, sustain, unforeseen, utilize, worsening
Filing tables
Filing exhibits
Related press release
KANT similar filings
Filing view
External links